Skip to content

Medical-device intelligence

NQD: Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

FDA product code NQD: Cardiac C-Reactive Protein, Antigen, Antiserum, And Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NQD
FDA device name
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class
2
Regulation number
866.5270
Medical specialty
Immunology
Review panel
IM

FDA definition

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

19 clearance records and 3 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from Jan 22, 2004 to Apr 2, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202610
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NQD · Cardiac C-Reactive Protein, Antigen, Antiserum, And Control193

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

22 matching records
Device / recordCompany in FDA recordSourceSource date
Tina-quant Cardiac high sensitivity CRP IIIK260026 · NQDRoche Diagnostics510(k)Apr 2, 2026FDA decision date
Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)K233242 · NQDSiemens Healthcare Diagnostics, Inc.510(k)Jan 18, 2024FDA decision date
CardioPhase® hsCRPK212559 · NQDSiemens Healthcare Diagnostics Products GmbH510(k)Dec 16, 2022FDA decision date
CRP VarioK173833 · NQDSENTINEL CH. SpA510(k)Sep 27, 2018FDA decision date
Tina-Quant (Latex) HS Test System (C-Reactive Protein (Latex) High Sensitive) The Tina-Quant CRP (Latex) High Sensitive Immunoturbidimetric assay…Z-1092-2017 · NQDRoche Diagnostics Operations, Inc.RecallJan 24, 2017FDA classification date
Siemens Acute Care" CCRP TestPak-in vitro diagnostic product intended to be used for calibration of the CCRP method on the Stratus CS analyzer Ca…Z-0614-2016 · NQDSiemens Healthcare Diagnostics IncRecallJan 7, 2016FDA classification date
Siemens Acute Care CCRP CalPak-in vitro diagnostic product intended to be used for calibration of the CCRP method on the Stratus CS analyzer Cata…Z-0616-2016 · NQDSiemens Healthcare Diagnostics IncRecallJan 7, 2016FDA classification date
ADVIA CHEMISTRY CARDIOPHASE HIGH SENSITIVITY C-REACTIVE PROTEIN (HSCRP), CALIBRATORSK081294 · NQDSiemens Healthcare Diagnostics, Inc.510(k)Jul 29, 2008FDA decision date
IMMAGE IMMUNOCHEMISTRY SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CCRP) REAGENTK071002 · NQDBeckman Coulter, Inc.510(k)Jun 21, 2007FDA decision date
SYNCHRON SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CRPH) REAGENTK070626 · NQDBeckman Coulter, Inc.510(k)May 4, 2007FDA decision date
IMMULITE 2500 HIGH SENSITIVITY C-REACTIVE PROTEIN, MODELS L5KCRP (200 TESTS), L5KCRP (600 TESTS)K071017 · NQDSiemens Medical Solutions Diagnostics510(k)May 2, 2007FDA decision date
STRATUS CS ACUTE CARE CARDIOPHASE HSCRP TESTPAKK062924 · NQDDade Behring, Inc.510(k)Dec 26, 2006FDA decision date
IMMULITE/IMMULITE 1000, IMMULITE 2000 HIGH SENSITIVITY CRPK063057 · NQDDiagnostic Products Corporation510(k)Dec 22, 2006FDA decision date
DIMENSION VISTA CARDIOPHASE HSCRP FLEX REAGENT CARTRIDGE, PROTEIN 2 CALIBRATOR, HSCRP CONTROL LOW, HSCRP 1 CONTROL HIGHK061802 · NQDDade Behring, Inc.510(k)Sep 11, 2006FDA decision date
STRATUS CS ACUTE CARE CARDIOPHASE HSCRP TEST PAK, CALPAK, DILPAKK060369 · NQDDade Behring, Inc.510(k)May 4, 2006FDA decision date
C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE TEST SYSTEM FOR COBAS INTEGRA INSTRUMENTSK053603 · NQDRoche Diagnostics Corp.510(k)Feb 9, 2006FDA decision date
DIMENSION CARDIOPHASE HIGH SENSITIVITY CRP FLEX REAGENT CARTRIDGEK053109 · NQDDade Behring, Inc.510(k)Dec 23, 2005FDA decision date
OLYMPUS CRP LATEX REAGENT, OSR6199; OLYMPUS CRP LATEX CALIBRATOR NORMAL SET, ODC0026; OLYMPUS CRP LATEX CALIBRATOR HIGHK051564 · NQDOlympus America, Inc.510(k)Aug 22, 2005FDA decision date
TINA-QUANT CRP (LATEX) HS TEST SYSTEM (C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE)K042485 · NQDRoche Diagnostics Corp.510(k)Oct 29, 2004FDA decision date
VITROS CHEMISTRY PRODUCTS HSCRP REAGENT, VITROS CHEMISTRY PRODUCTS CALIBRATOR KIT 17, VITROS CHEMISTRY PRODUCTS FSK041799 · NQDOrtho-Clinical Diagnostics, Inc.510(k)Aug 25, 2004FDA decision date
OLYMPUS CRP LATEX IMMUNOTURBIDIMETRIC REAGENTK041668 · NQDOlympus America, Inc.510(k)Aug 19, 2004FDA decision date
N HIGH SENSITIVITY CRPK033908 · NQDDade Behring, Inc.510(k)Jan 22, 2004FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗